OliX Pharmaceuticals, Inc.
Clinical-stage company developing RNAi therapeutics for dermal and ophthalmic diseases.
226950 | KO
Overview
Corporate Details
- ISIN(s):
- KR7226950004
- LEI:
- Country:
- South Korea
- Address:
- 경기도 성남시 수정구 고등동 608-3 -, 성남시
- Website:
- https://olixpharma.com
- Sector:
- Manufacturing
Description
OliX Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company specializing in the development of therapeutics based on RNA interference (RNAi) technology. The company leverages its proprietary asymmetric siRNA (asiRNA) platform to create treatments that selectively silence disease-causing genes. Its research and development efforts are focused on building a robust pipeline of drug candidates targeting a variety of illnesses with high unmet medical needs. The pipeline has a particular emphasis on ophthalmic and dermal disorders, with key programs addressing conditions such as hypertrophic scars, age-related macular degeneration (AMD), and other fibrotic and ocular diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-08-30 00:00 |
[기재정정]신규시설투자등
|
Korean | 11.2 KB | ||
| 2024-08-28 00:00 |
기업설명회(IR)개최
|
Korean | 6.7 KB | ||
| 2024-08-13 00:00 |
반기보고서 (2024.06)
|
Korean | 1.6 MB | ||
| 2024-08-09 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 143.1 KB | ||
| 2024-07-30 00:00 |
불성실공시법인미지정 (지정유예)
|
Korean | 5.8 KB | ||
| 2024-07-22 00:00 |
기타경영사항(자율공시) (전환우선주의 보통주 전환청구(제1회차, 제2회차))
|
Korean | 17.7 KB | ||
| 2024-07-12 00:00 |
불성실공시법인지정예고 (공시번복 2건)
|
Korean | 6.7 KB | ||
| 2024-06-24 00:00 |
투자판단관련주요경영사항 (건성 및 습성 황반변성 치료제 OLX301A, 습성황반변성 및 망막하섬유화증 치료제 OLX30…
|
Korean | 9.5 KB | ||
| 2024-05-30 00:00 |
투자판단관련주요경영사항(임상시험계획변경승인) (OLX75016비알코올성지방간염 치료제의 호주 제1상 임상시험 계획 변경…
|
Korean | 17.9 KB | ||
| 2024-05-24 00:00 |
투자판단관련주요경영사항(임상시험계획변경승인신청) (OLX75016(비알코올성지방간염 치료제)의 호주 제1상 임상시험 계…
|
Korean | 17.0 KB | ||
| 2024-05-14 00:00 |
분기보고서 (2024.03)
|
Korean | 1.3 MB | ||
| 2024-05-03 00:00 |
기타경영사항(자율공시) (전환우선주의 보통주 전환청구)
|
Korean | 15.8 KB | ||
| 2024-04-25 00:00 |
투자판단관련주요경영사항(임상시험결과) (흉터 재건술 이후 재발 억제 보조요법으로서 OLX10010의 유효성 평가를 위한…
|
Korean | 13.2 KB | ||
| 2024-04-02 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 149.5 KB | ||
| 2024-03-28 00:00 |
정기주주총회결과
|
Korean | 24.0 KB |
Automate Your Workflow. Get a real-time feed of all OliX Pharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for OliX Pharmaceuticals, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for OliX Pharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
